Trial Profile
To Evaluate the Effects of mirabegron on storage and voiding function in patients with overactive bladder that is unresponsive to antimuscarinic treatment, based on a urodynamic study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 02 Dec 2015 New trial record